Stay updated on Daratumumab & DLI for Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab & DLI for Relapsed AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing v3.6.0, indicating an internal update to the page framework; no study content or visible details appear to be affected.
    Difference
    0.1%
    Check dated 2026-06-30T02:12:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting, while also displaying a new revision tag (v3.6.0) and noting that recruitment is no longer open.
    Difference
    0.5%
    Check dated 2026-06-15T22:21:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.4 to v3.5.5. This indicates a minor deployment update and does not modify the study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-08T17:37:45.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, indicating a new software revision was applied. The previous revision v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-18T03:56:13.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s release/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a ClinicalTrials.gov site revision without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:22:41.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2; no user-facing content changes are evident.
    Difference
    0.1%
    Check dated 2026-04-19T13:38:20.000Z thumbnail image

Stay in the know with updates to Daratumumab & DLI for Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab & DLI for Relapsed AML Clinical Trial page.